91˿Ƶ

Nada Jabado

Academic title(s): 

Professor

MD, PhD, FRSC

Nada Jabado
Contact Information
Address: 

91˿Ƶ Health Centre Research Institute
1001 Boulevard, EM1 2242
Montreal, Quebec, H4A 3J1

Email address: 
nada.jabado [at] mcgill.ca
Division: 
Hematology-Oncology
Area(s): 
Epigenetics
Molecular genetics
Degree(s): 
  • MSc, Biochemistry, Université de Paris VI, Paris, France, 1992
  • DEA, Immunology, Institut Pasteur, Paris, France, 1993
  • MD, Medicine, Université de Paris VI, Inst Marie Curie, Paris, France, 1995
  • DESS, Pediatrics, Université de Paris VI, Paris, France, 1995
  • PhD, Immunology, Université de Paris VI, Inst Marie Curie, Paris, France, 1998
  • Postdoc, Biochemistry, 91˿Ƶ, Montreal, Quebec, Canada, 2003
Biography: 

Dr. Nada Jabado is a Professor of Pediatrics at 91˿Ƶ and a pediatric neuro-oncologist at the Montreal Children’s Hospital, as well as a senior scientist at the Research Institute of the 91˿Ƶ Health Centre. She completed her residency in pediatrics with a specialization in hemato-oncology. She also obtained a PhD in Immunology in Paris, France, followed by a postdoctoral fellowship in biochemistry at 91˿Ƶ. Dr. Jabado began her career as an independent investigator at 91˿Ƶ in 2003, pioneering a research program in pediatric brain tumours. She joined the Department of Pediatrics because helping sick children through clinical practice and research has always been my greatest passion. Dr. 岹’s research group uncovered that pediatric high-grade astrocytomas (HGA) are molecularly and genetically distinct from adult tumours. More importantly, they identified a new molecular mechanism driving pediatric HGA, namely recurrent somatic driver mutations in the tail of histone 3 variants (H3.3 and H3.1). This ground-breaking work has created a paradigm shift in cancer that has revolutionized this field, as the epigenome was a previously unsuspected hallmark of oncogenesis, thus linking development and what we now know are epigenetically-driven cancers.

Areas of expertise: 
  • Pediatric brain tumours
  • Gliomas
  • Astrocytomas
  • Epigenetics
  • Next generation sequencing
Areas of interest: 
  • Origin and pathogenesis of pediatric brain tumours
  • Role of epigenetics in development and disease
Awards, honours, and fellowships: 
  • Maude Abbott Prize, Faculty of Medicine, 91˿Ƶ, 2012
  • Canadian Cancer Society William E. Rawls Award, 2012
  • Canadian Gene Cure Foundation's (CGCF), Champions of Genetics Awards. Named Next generation Champion of Genetics, 2011-2013
  • Atena Prize. Awarded by the Fondazione Atena Onlus for excellence in research in Neurosciences, Rome, Italy, 2014
  • Fellow, Royal Society of Canada, Academy of Science, Life Sciences Division, 2016
  • Member, Governing Council, Canadian Institute of Health Research, Health Canada, 2017
  • Member, Canadian Academy of Health Sciences, 2018
  • Women of Action, Israel Cancer Research Fund, 2018
  • Pediatric Academic Leadership, Clinician Investigator Award, Pediatric Chairs of Canada, 2019
  • Canada Research Chair in Pediatric Oncology, Tier 1, 2019
  • Dr. Chew Wei Memorial Prize in Cancer Research, 2020
  • Canadian Cancer Society’s 2020 Robert L. Noble Prize, 2021
  • Fédération des Médecins Spécialistes du Québec (FMSQ) Prix de la recherche 2021, co-awardee, 2021
Back to top